Leukocyte immunoglobulin-like receptor subfamily B member 4 is a protein that in humans is encoded by the LILRB4gene.
This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. The receptor can also function in antigen capture and presentation. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene.
^Samaridis J, Colonna M (Apr 1997). "Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways". Eur J Immunol. 27 (3): 660–5. PMID9079806. doi:10.1002/eji.1830270313.
^Wang, L L; Blasioli J; Plas D R; Thomas M L; Yokoyama W M (Feb 1999). "Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B". J. Immunol. UNITED STATES. 162 (3): 1318–23. ISSN0022-1767. PMID9973385.
Arm JP, Nwankwo C, Austen KF (1997). "Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor". J. Immunol. 159 (5): 2342–9. PMID9278324.
Kuroiwa A, Yamashita Y, Inui M, et al. (1998). "Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene". J. Biol. Chem. 273 (2): 1070–4. PMID9422771. doi:10.1074/jbc.273.2.1070.
Borges L, Hsu ML, Fanger N, et al. (1998). "A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules". J. Immunol. 159 (11): 5192–6. PMID9548455.
Wang LL, Blasioli J, Plas DR, et al. (1999). "Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B". J. Immunol. 162 (3): 1318–23. PMID9973385.
Heinzmann A, Blattmann S, Forster J, et al. (2000). "Common polymorphisms and alternative splicing in the ILT3 gene are not associated with atopy". Eur. J. Immunogenet. 27 (3): 121–7. PMID10940079. doi:10.1046/j.1365-2370.2000.00214.x.
Liu WR, Kim J, Nwankwo C, et al. (2000). "Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4". Immunogenetics. 51 (8–9): 659–69. PMID10941837. doi:10.1007/s002510000183.
Young NT, Canavez F, Uhrberg M, et al. (2001). "Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex". Immunogenetics. 53 (4): 270–8. PMID11491530. doi:10.1007/s002510100332.
Chang CC, Ciubotariu R, Manavalan JS, et al. (2002). "Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4". Nat. Immunol. 3 (3): 237–43. PMID11875462. doi:10.1038/ni760.
LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED (2005). "HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells". FASEB J. 19 (6): 662–4. PMID15670976. doi:10.1096/fj.04-1617fje.
Garner LI, Salim M, Mohammed F, Willcox BE (2006). "Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies". Protein Expr. Purif. 47 (2): 490–7. PMID16406677. doi:10.1016/j.pep.2005.11.020.
Kim-Schulze S, Scotto L, Vlad G, et al. (2006). "Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells". J. Immunol. 176 (5): 2790–8. PMID16493035. doi:10.4049/jimmunol.176.5.2790.